SynergiQc program for biopharmaceutical research

For biotechnology and life sciences companies in Quebec, advancing biopharmaceutical research often depends on strong ties with the public research ecosystem. The SynergiQc program for biopharmaceutical research is designed to support exactly that kind of collaboration, helping businesses move promising scientific ideas toward real-world applications. Delivered by CQDM, the Quebec Consortium for Drug Discovery, the program focuses on industrial-scale R&D projects carried out jointly by Quebec companies and public research centres such as universities, hospitals, and research institutes.

SynergiQc is well suited for SMEs and larger enterprises working on drug discovery, therapeutic development, or related life sciences innovation. Projects typically involve early to mid-stage research and aim to strengthen technological capabilities, accelerate knowledge transfer, and generate tangible economic benefits for Quebec. Funding is non-repayable and can reach up to around $2 million per project, covering a meaningful share of eligible research costs. The level of support varies based on the size of the participating company, making the program accessible to a wide range of business profiles, including biotech firms, pharmaceutical companies, and contract research organizations.

With applications currently being accepted and additional opportunities available in specialized research areas, SynergiQc can be a powerful lever for companies looking to scale their R&D through collaboration. Reviewing the full program details can help determine whether your next research initiative is a good fit.